The top 20 highest burdened countries (in disability-adjusted life years) account for more
than 75% of the global burden of viral hepatitis. An effective response in these 20 countries …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Prevention of mother-to-child transmission of hepatitis B virus (HBV) infection is a
cornerstone of efforts to support progress towards elimination of viral hepatitis. Current …

Background In 2020, WHO recommended the addition of peripartum antiviral prophylaxis
(PAP) to hepatitis B birth dose vaccination (HepB-BD) and hepatitis B infant vaccination …

There are 82 million people living with hepatitis B (PLWHB) in the World Health
Organization Africa region, where it is the main cause of liver disease. Effective vaccines …

ABSTRACT In sub-Saharan Africa (SSA), chronic viral hepatitis B (HBV) affects more than
60 million people. Mother-to-child transmission is a major contributor to the ongoing HBV …

With the advent of a variety of vaccines against viral infections, there are multiple viruses that
can be prevented via vaccination. However, breakthrough infections or uncovered strains …

Chronic hepatitis B poses a significant global burden, modulating immune cells, leading to
chronic inflammation and long-term damage. Due to its hepatotropism, the hepatitis B virus …

Background Although hepatitis B infection is highly endemic in Africa, information on its
epidemiology among pregnant women in the region is limited. Therefore, this systematic …

The persistent burden of chronic hepatitis B among≤ 5-year-old children in Africa suggests
missed opportunities for controlling mother-to-child transmission (MTCT) of the hepatitis B …